Koh, Adrian <br/><br/>
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.  [electronic resource] 

 -  JAMA ophthalmology  11 2017 
 - 1206-1213 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6173 
<br/><br/><label>Standard No.: </label>10.1001/jamaophthalmol.2017.4030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Choroid--blood supply<br/>Choroid Diseases--diagnosis<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fundus Oculi<br/>Humans<br/>Injections, Intravenous<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Photochemotherapy--methods<br/>Photosensitizing Agents--administration & dosage<br/>Polyps--diagnosis<br/>Porphyrins--administration & dosage<br/>Ranibizumab--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome<br/>Verteporfin